Angiogenic factors stimulate mast-cell migration

Blood

Volumn 86, Issue 7, 1995, Pages 2488-2493

  Gruber, Barry L ^a   Marchese, Mary J ^b   Kew, Richard ^b  

^a STONY BROOK UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; CHEMOTACTIC FACTOR; EPIDERMAL GROWTH FACTOR; GENISTEIN; PERTUSSIS TOXIN; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; CELL INTERACTION; CELL MIGRATION; CHEMOKINESIS; CHEMOTAXIS; CONTROLLED STUDY; DESENSITIZATION; MAST CELL; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL;

EID: 0029166407     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v86.7.2488.2488     Document Type: Article

References (34)

1. Takeda K, Hatamochi A, Ueki H: Increased number of mast cells accompany enhanced collagen synthesis in linear localized scleroderma. Arch Dermatol Res 281:288, 1989
2. Meininger CJ, Zetter BR: Mast cells and angiogenesis. Cancer Biol 3:73, 1992
3. Jakobsson AE: Angiogenesis induced by mast cell secretion in rat peritoneal connective tissue is a process of three phases. Microvasc Res 47:252, 1994
4. Kessler DA, Langer RS, Pless NA, Folkman J: Mast cells and tumor angiogenesis. Int J Cancer 18:703, 1976
5. Wilson DJ: Mast cells are present during angiogenesis in the chick extraembryonic vascular system. Experientia 41:269, 1985
6. Yang EY, Moses HL: Transforming growth factor-β1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 111:731, 1990
7. Gruber BL, Marchese MJ, Kew R: Transforming growth factor-β1 mediates chemotaxis of mast cells. J Immunol 152:5860, 1994
8. Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD, Dvorak AM, Galli SJ, Dorf ME: Interleukin 3-dependent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 170:245, 1989
9. Fulk W, Goodwin RH, Leonard EJ: A 48-well micro-chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Methods 33:239, 1980
10. D'Amore PA: Mechanisms of endothelial growth control. Am J Respir Cell Mol Biol 6:1, 1992
11. Klagsbrun M, D'Amore PA: Regulators of angiogenesis. Annu Rev Physiol 53:217, 1991
12. Westermark B, Siegbahn A, Heldin C-H, Claesson-Welsh L: B-type receptor for platelet-derived growth factor mediates a chemotactic response by means of ligand-induced activation of the receptor protein-tyrosine kinase. Proc Natl Acad Sci USA 87:128, 1990
13. Raines EW, Ross R: Platelet-derived growth factor in vivo, in Westermark B, Sorg C (eds): Cytokines, vol 5. Basel, Switzerland, Karger, 1993, p 74
14. Ferrara N, Houck K, Jakeman L, Leung DW: Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13:18, 1992
15. Connolly DT, Heuvelman DM, Nelson R, Olander JV, Epley BL, Delfino JJ, Siegel NR, Leimgruber RM, Feder J: Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 84:1470, 1989
16. Clauss M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YCE, Olander JV, Connolly DT, Stern D: Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 172:1535, 1990
17. Haraguchi M, Mitadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K, Akiyama S: Angiogenic activity of enzymes. Nature 368:198, 1994
18. Ullrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61:203, 1990
19. Vaismann N, Gospodarowicz D, Neufeld G: Characterization of the receptor for vascular endothelial growth factor. J Biol Chem 265:19461, 1990
20. Sadowski HB, Shuai K, Darnell JEJ, Gilman MZ: A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 261:1739, 1993
21. Kavanaugh WM, Williams LT: An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science 266:1862, 1994
22. Qu Z, Planck SR, Rosenbaum JT: Mast cells rather than macrophages or synoviocytes are the major source of basic fibroblast growth factor in arthritic joints. Arthritis Rheum 37:S305, 1994 (suppl)
23. Shweiki D, Itin A, Soffer D, Keshet E: Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843, 1992
24. Falanga V, Qian SW, Danielpour D, Katz MH, Roberts AB, Sporn MB: Hypoxia upregulates the synthesis of TGF-beta1 by human dermal fibroblasts. J Invest Dermatol 97:634, 1991
25. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C: Macrophages and angiogenesis. J Leukoc Biol 55:410, 1994
26. Eady RAJ, Cowen T, Marshall TF, Plummer V, Greaves MW: Mast cell population density, blood vessel density and histamine content in normal skin. Br J Dermatol 100:635, 1979
27. Glowacki J, Mulliken JB: Mast cells in hemangiomas and vacular malformations. Pediatrics 70:48, 1982
28. Poole TJ, Zetter BR: Mast cell chemotaxis to tumor-derived factors. Cancer Res 43:5857, 1983
29. v exhibit a decreased rate of tumor angiogenesis. Int J Cancer 42:48-52, 1988
30. Matsuura N, Zetter BR: Stimulation of mast cell chemotaxis by interleukin 3. J Exp Med 170:1421, 1989
31. Meininger CJ, Yano H, Rottapel R, Bernstein A, Zsebo KM, Zetter BR: The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 79:958, 1992
32. Thompson HL, Burbelo PD, Yamada Y, Kleinman HK, Metcalfe DD: Mast cells chemotax to laminin with enhancement after IgE-mediated activation. J Immunol 143:4188, 1989
33. Taub D, Dastych J, Inamura N, Upton J, Kelvin D, Metcalfe D, Oppenheim J: Bone marrow-derived murine mast cells migrate, but do not degranulate, in response to chemokines. J Immunol 154:2393, 1995
34. Nilsson G, Butterfield JH, Nilsson K, Siegbahn A: Stem cell factor is a chemotactic factor for human mast cells. J Immunol 153:3717, 1994